# Pfizer, Inc. – FDA Inspection, Dec 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/pfizer-inc/d45be9cf-ef2e-4d2d-9638-08e91b31a22c
Source feed: FDA_Inspections

> FDA inspection 1256477 of Pfizer, Inc., December 13, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 58. Form 483 issued. 25 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256477
- Company Name: Pfizer, Inc.
- Inspection Date: 2024-12-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1284680 - 2025-10-24
- FDA Inspection 1249289 - 2024-08-30
- FDA Inspection 1230476 - 2024-07-19
- FDA Inspection 1204434 - 2023-04-19
- [FDA Inspection 1190580 - 2022-10-28](https://www.keypedia.com/records/fda_inspections/pfizer-inc/1522426b-07b3-484f-815d-78e94844b9ce)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/pfizer-inc/4b87fbf2-bec7-4fde-adf0-4207cd7d93ff

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
